Insider Transactions in Q4 2022 at Clovis Oncology, Inc. (CLVS)
Insider Transaction List (Q4 2022)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Nov 02
2022
|
Lindsey Rolfe Officer |
SELL
Open market or private sale
|
Direct |
4,261
-1.86%
|
$0
$0.98 P/Share
|
|
Nov 02
2022
|
Daniel W Muehl Officer |
SELL
Open market or private sale
|
Direct |
4,579
-2.17%
|
$0
$0.98 P/Share
|
|
Nov 02
2022
|
Thomas C. Harding Officer |
SELL
Open market or private sale
|
Indirect |
63
-1.63%
|
$0
$0.98 P/Share
|
|
Nov 02
2022
|
Thomas C. Harding Officer |
SELL
Open market or private sale
|
Direct |
1,703
-4.28%
|
$0
$0.98 P/Share
|
|
Nov 02
2022
|
Gillian C Ivers Read Officer |
SELL
Open market or private sale
|
Direct |
3,681
-0.63%
|
$0
$0.98 P/Share
|
|
Nov 02
2022
|
Paul Edward Gross Officer |
SELL
Open market or private sale
|
Direct |
4,730
-2.38%
|
$0
$0.98 P/Share
|
|
Nov 01
2022
|
Lindsey Rolfe Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
8,374
+3.52%
|
-
|
|
Nov 01
2022
|
Daniel W Muehl Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
10,248
+4.62%
|
-
|
|
Nov 01
2022
|
Thomas C. Harding Officer |
BUY
Exercise of conversion of derivative security
|
Indirect |
181
+4.47%
|
-
|
|
Nov 01
2022
|
Thomas C. Harding Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
3,374
+7.81%
|
-
|
|
Nov 01
2022
|
Gillian C Ivers Read Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
8,374
+1.4%
|
-
|
|
Nov 01
2022
|
Paul Edward Gross Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
10,248
+4.9%
|
-
|
|
Oct 03
2022
|
Thomas C. Harding Officer |
SELL
Open market or private sale
|
Indirect |
6
-0.16%
|
$6
$1.29 P/Share
|
|
Oct 01
2022
|
Thomas C. Harding Officer |
BUY
Exercise of conversion of derivative security
|
Indirect |
15
+0.41%
|
-
|